Dergiler / Erciyes Medical Journal / 2016 / Cilt: 38 - Sayı: 2

Humans as a Source of Colistin Resistance: In Silico Analysis of Public Metagenomes for the mcr-1 Gene in the Gut Microbiome

Sayfa
59–61
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Further investigations, such as the surveillance of dissemination of related genes, in countries where colistin resistance has become a serious problem, like Turkey, should be considered.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Colistin is our last line of defense in the treatment of infections caused by multidrug-resistant gram-negative pathogens.
📊
Temel Bulgular & Veri:In a recent study, a plasmid-mediated colistin resistance gene (mcr-1) was identified for the first time.
💡
Sonuç & Katkı:Further investigations, such as the surveillance of dissemination of related genes, in countries where colistin resistance has become a serious problem, like Turkey, should be considered.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Colistin is our last line of defense in the treatment of infections caused by multidrug-resistant gram-negative pathogens. However, resistance against colistin has been observed worldwide. In a recent study, a plasmid-mediated colistin resistance gene (mcr-1) was identified for the first time. The purpose of the present study was to conduct an in silico search for the mcr-1 gene and the plasmid harboring it in a cohort of human gut microbiomes, which have already been deposited in public metagenome databases in different geographies. Materials and Methods: The gut metagenomes of 344 Chinese and 145 European individuals were investigated. Each metagenome sample consisted of sequencing reads obtained from next-generation sequencing. Each DNA read was aligned against the entire mcr-1 and pHNSHP45 plasmid sequences using the BLASTn program. A nucleotide identity threshold of 95% similarity was set, and the reads aligned under that similarity were filtered out.Results: According to our investigation, 6 out of the 344 individuals in the Chinese cohort harbored the mcr-1 gene and close homologs of pHNSHP45 plasmid in their gut microbiota, whereas no related genetic elements were found in the European cohort.Conclusion: As the human gut microbiome is one of the key reservoirs of the resistome, the presence of the mcr-1 gene in human microbiota is alarming. It can be said that the dissemination of colistin resistance genes will be more prevalent in the clinic. Further investigations, such as the surveillance of dissemination of related genes, in countries where colistin resistance has become a serious problem, like Turkey, should be considered.

🔖

Bu Makaleye Atıf Yap

GÜNDOĞDU, A., NALBANTOĞLU, Ö. U. (2016). Humans as a Source of Colistin Resistance: In Silico Analysis of Public Metagenomes for the mcr-1 Gene in the Gut Microbiome. Erciyes Medical Journal, Cilt: 38 - Sayı: 2, 59–61. https://ajindex.com/articles/203585

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005
  2. 40(9): 1333-41. [CrossRef] Giamarellou H. Multidrug-resistant Gram-negative bacteria: how to treat and for how long. Int J Antimicrob Agents 2010
  3. 36(Suppl 2): S50-4. [CrossRef] Cai Y, Chai D, Wang R, Liang B, Bai N. Colistin resistance of Aci- netobacter baumannii: clinical reports, mechanisms and antimicro- bial strategies. J Antimicrob Chemother 2012
  4. 67(7): 1607-15. [CrossRef] Keske Ş, Yılmaz GR, Güven T, Güner R, Taşyaran MA. A health care-associated pneumonia case due to colistin resistant Acinetobacter baumannii. J Microbiol Infect Dis 2012
  5. 4(3): 111-13. [CrossRef] Ah YM, Kim AJ, Lee JY. Colistin resistance in Klebsiella pneumonia. Int J Antimicrob Agents 2014
  6. 44(1): 8-15. [CrossRef] Labarca J, Poirel L, Özdamar M, Türkoğlu S, Hakko E, Nordmann P. KPC-producing Klebsiella pneumoniae, finally targeting Turkey. New Microbes New Infect 2014
  7. 2(2): 50-1. [CrossRef] Adams MD, Nickel GC, Bajaksouzian S, Lavender H, Murthy AR, Jacobs MR, et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. An- timicrob Agents Chemother 2009
  8. 53(9): 3628-34. [CrossRef] Snitkin ES, Zelazny AM, Thomas PJ, Stock F, NISC Comparative Sequencing Program Group, Henderson DK, et al. Tracking a hos- pital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 2012
  9. 4(148): 148ra116. [CrossRef] Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer R, et al. Emer- gence of plasmid-mediated colistin resistance mechanism MCR1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2015
  10. 16(2): 161-8 [CrossRef] Hasman H, Hammerum AM, Hansen F, Hendrikse RS, Olesen B, Agersİ Y, et al. Detection of mcr-1 encoding plasmid-mediated colis- tin resistant Escherichia coli isolates from human bloodstream infec- tion and imported chicken meat, Denmark 2015. Euro Surveill 2015
  11. 20(49): pii=30085. [CrossRef] Arcilla MS, van Hattem JM, Matamoros S, Melles DC, Penders J, de Jong MD, et al. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis 2016
  12. 16(2): 147-9. [CrossRef] Forslund K, Sunagawa S, Kultima JR, Mende DR, Arumugan B, Typas A, et al. Country-specific antibiotic use practices impact the human gut resistome. Genome Res 2013
  13. 23(7): 1163-9. [CrossRef] Qin J, L